OVERVIEW
Despite its high prevalence worldwide, COPD often remains undiagnosed and untreated. This limits individuals’ access to appropriate care and treatment. It has been shown that early diagnosis and regular assessment of symptom severity can improve patient outcomes, quality of life, and survival. In this webinar, Dr Nicola Hanania will discuss how to assess COPD symptom severity, how to identify patients who are not being adequately controlled with maintenance therapy, and how emerging COPD treatments can serve the unmet therapeutic needs of patients with COPD.
GOAL STATEMENT
The goal of this activity is for clinicians to better identify patients with COPD in clinical practice and understand the role of emerging targeted therapeutic strategies to improve the standard of care in patients with COPD.
LEARNING OBJECTIVES
Upon completion of this activity, learners will: Have increased knowledge regarding the[LIST] [ITEM]Unmet medical needs of patients with COPD[/LIST]Have greater competence related to[LIST] [ITEM]The clinical assessment of COPD [/LIST]Demonstrate greater confidence in their ability to[LIST] [ITEM]Understand the implications of emerging therapeutics for improving the standard of care for patients with COPD[/LIST]
ACCREDITATION STATEMENT
[JALOGO] [MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 0.50 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Supported by an independent medical education grant from [bold]Regeneron Pharmaceuticals, Inc[/bold] and [bold]Sanofi.[/bold]